About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,756 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,756 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4761-4780 of 9,756 trials

CompletedStudy to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart FailureThe purpose of this study is to evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise…NCT03759392·Anchorage, Alaska and 80 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

TerminatedTrial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab's safety and efficacy in non-ambulatory participants with DMD.NCT02606136·Los Angeles, California and 9 others

CompletedEvaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.This trial is conducted globally. The aim of this trial is to evaluate the haemostatic effect of NNC 0129-0000-1003 during surgical procedures in subjects with haemophilia A.NCT01489111·Phoenix, Arizona and 69 others

RecruitingStudy of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)Prospective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries prior…NCT07062471·Little Rock, Arkansas and 24 others

CompletedA Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular DegenerationStudy GR40548 is a Phase III, randomized, multicenter, open-label (visual assessor \[VA\]-masked), active-comparator study designed to assess the efficacy, safety, and…NCT03677934·Mesa, Arizona and 76 others

TerminatedThe Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep ApneaThe purpose of this trial is to evaluate the long-term effects of Nocturnal Oxygen Therapy (NOXT) on the mortality and morbidity of patients with stable heart failure and a…NCT03745898·Tucson, Arizona and 25 others

Active not recruitingEfficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery \[neoadjuvant…NCT03425643·Gilbert, Arizona and 226 others

CompletedIxekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)15 patients with PRP will be treated with ixekizumab for 24 weeks to determine safety and efficacy.NCT03485976·Portland, Oregon

CompletedGR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer PatientsThis study is a dose escalation of GR-MD-02 with the standard therapeutic dose of pembrolizumab in patients with advanced melanoma, non-small cell lung cancer, and head and neck…NCT02575404·Portland, Oregon

TerminatedA Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)A randomized controlled trial comparing safety and efficacy of carboplatin and paclitaxel plus or minus sorafenib in chemonaive patients with stage III-IV non-small cell lung…NCT00300885·Birmingham, Alabama and 201 others

CompletedSUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)This is a retrospective international, multi-center, non-interventional cohort study based on use of data derived from established medical records and secondary analysis of…NCT02543476·La Jolla, California and 17 others

CompletedEfficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderThe purpose of this study is to determine the safety and efficacy of vortioxetine, once daily (QD), in adults with generalized anxiety disorder.NCT00730691·Anaheim, California and 65 others

CompletedEfficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne VulgarisThe purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.NCT01498874·Hot Springs, Arkansas and 18 others

CompletedA Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3The purpose of this study is to examine how rIL-2 affects HIV-positive patients with CD4 counts over 300 cells/mm3 who are on anti-HIV drug therapy.NCT00000949·San Francisco, California and 14 others

TerminatedA Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseThe purpose of this study is to compare the safety and efficacy of 2 mg, 4 mg, and 20 mg of ABT-089 BID to placebo in adults with Alzheimer's disease.NCT00069849·Fresno, California and 7 others

CompletedOmega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal HyperplasiaRATIONALE: Polyunsaturated fatty acids are important for normal growth and development.NCT00627276·Portland, Oregon and 1 other

CompletedTreatment Alternatives in iSGS (NoAAC PR-02 Study)The study is aimed at answering the questions; (1) How well do the most commonly used treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each…NCT02481817·Birmingham, Alabama and 41 others

TerminatedA Study of ONCO-DOX in Locally Advanced Hepatocellular CarcinomaThis is a prospective, multicenter study that will be conducted at up to 40 centers in the United States and Outside United States (OUS).NCT02460991·Birmingham, Alabama and 5 others

CompletedGenetic and Biochemical Markers of Interferon-Induced Depression.The purpose of this study is to identify predictors and associated biochemical markers of interferon-induced depression.NCT00252538·Long Beach, California and 2 others

CompletedTAXUS PERSEUS WorkhorseThe purpose of the TAXUS PERSEUS Workhorse trial is to evaluate the safety and efficacy of the next-generation Boston Scientific TAXUS paclitaxel-eluting coronary stent system…NCT00484315·Birmingham, Alabama and 89 others

PreviousPage 239 of 488Next

in Portland

Heart Diseasein Portland